News

Press Releases

Filter By

2023/10/30

WuXi AppTec Continued Solid Growth in the First Three Quarters of 2023 on Top of an Exceptionally Strong Year in 2022, with Profit Growth Continuously Exceeding Revenue Growth

(SHANGHAI, October 30, 2023) 鈥 WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the third quarter and nine months ended September 30, 2023 (鈥淩eporting Period鈥)

Read more

2023/07/31

WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022

(SHANGHAI, July 31, 2023) 鈥 WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first half ending June 30, 2023 (鈥淩eporting Period鈥).

Read more

2023/04/24

WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022

(SHANGHAI, April 24, 2023) 鈥 WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first quarter ending March 31, 2023 (鈥淩eporting Period鈥).

Read more

2023/03/20

WuXi AppTec Reports Record Results in 2022

SHANGHAI, March 20, 2023 鈥 WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its annual results for the year ending December 31, 2022 (鈥淩eporting Period鈥).

Read more

2023/02/16

WuXi AppTec Named 鈥淚ndustry Mover鈥 in S&P Global Sustainability Yearbook 2023

Shanghai, February 15, 2023 鈥 WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services for the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, announced today that it received the 鈥淚ndustry Mover鈥 award in the S&P Global Sustainability Yearbook 2023. WuXi AppTec is the only company to be named as 鈥淚ndustry Mover鈥 this year from the Life Science Tools & Services industry.

Read more
銆愮綉绔欒垎鍥俱銆恠itemap銆
【网站舆图】【sitemap】